Related references
Note: Only part of the references are listed.Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Pingzheng Mo et al.
CLINICAL INFECTIOUS DISEASES (2021)
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Jin-jin Zhang et al.
ALLERGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (vol 17, pg 851, 2020)
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia
Davide Colombi et al.
RADIOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Sex difference and smoking predisposition in patients with COVID-19
Hua Cai
LANCET RESPIRATORY MEDICINE (2020)
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020
Nancy Chow et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Roger L. Papke et al.
NEUROPHARMACOLOGY (2020)
Cigarette smoking and the occurrence of influenza - Systematic review
H. Lawrence et al.
JOURNAL OF INFECTION (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
The cholinergic anti-inflammatory pathway: an innovative treatment strategy for respiratory diseases and their comorbidities
Mitsuhiro Yamada et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Nicotine and autoimmunity: The lotus' flower in tobacco
Joao Pedro Gomes et al.
PHARMACOLOGICAL RESEARCH (2018)
Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey
Shiwei Liu et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014
Basem M. Alraddadi et al.
EMERGING INFECTIOUS DISEASES (2016)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
The α7 Nicotinic Acetylcholine Receptor Complex: One, Two or Multiple Drug Targets?
Morten S. Thomsen et al.
CURRENT DRUG TARGETS (2012)
Nicotine replacement therapy for smoking cessation
Lindsay F. Stead et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Nicotine Exerts an Anti-inflammatory Effect in a Murine Model of Acute Lung Injury
Jon Mabley et al.
INFLAMMATION (2011)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
H Wang et al.
NATURE (2003)
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
LV Borovikova et al.
NATURE (2000)
Share Paper
